硝酸甘油抗骨质疏松症的研究进展

www.yongyao.net　　2009-8-24 15:56:28　　来源：　　责任编辑：

分享到：

[参考文献]
[ 1 ] 　GRANTM K, EIFANKAHANY E E. Therapeutic interventions targeting the nitric oxide system: Current and potential uses in obstetrics, bone disease and erectile dysfunction [ J ]. L ife Sci, 2004,74 (10) : 1701 - 1721.
[ 2 ] 　TURNER C H, OWAN I, JACOB D S, et al. Effects of nitric oxide synthase inhibitors on bone formation in rats [ J ]. B one, 1997, 21(6) : 487 - 490.
[ 3 ] 　W IMALAWANSA S, CHAPA T, FANG L, et al. Frequencydependent effect of nitric oxide donor nitroglycerin on bone [ J ]. J B oneM iner Res, 2000, 15 (6) : 1119 - 1125.
[ 4 ] 　VANT HOF R J, RALSTON S H, JOHNSTON P W, et al. Nitricoxide’s function In bone cells [ J ]. CurrOpin O rthop, 1997, 8 (1) :19 - 24.
[ 5 ] 　W IMALAWANSA S J, DE MARCO G, GANGULA P, et al. Nitricoxide donor alleviates ovariectomy2induced bone loss [ J ]. B one,1996, 18 (2) : 301 - 304.
[ 6 ] 　W IMALAWANSA S J. Restoration of ovariectomy2induced osteopenia by nitroglycerin [ J ]. Calcif Tissue Int, 2 000, 66 (1) : 56 - 60.
[ 7 ] 　W IMALAWANSA S J, CHAPA M T, YALLAMPALL I C, et al. Prevention of corticosteroid2 induced bone loss with nitric oxide donor nitroglycerin in male rats[ J ]. B one, 1997, 21 (1) : 275 - 280.
[ 8 ] 　W IMALAWANSA S J. Nitroglycerin therapy is as efficacious as standard estrogen rep lacement therapy ( Premarin ) in p revention of oophorectomy2induced bone loss: a human p ilot clinical study[ J ]. JB oneM iner Res, 2000, 15 (10) : 2240 - 2244.
[ 9 ] 　SOPH IE A J, CELESTE J H,DENN IS B, et al. The effects of organic nitrates on osteoporosis: a randomized controlled trial [ J ]. Trials,2006, 7 (1) : 10.
[ 10 ] 　SOPH IE A J,WARREN S B,DOUGLAS C B, et al. Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures[ J ]. J B M in Res, 1998, 13 (11) : 1755 - 1759.
[ 11 ] 　FEEL ISCH M. The biochemical pathways of nitric oxide formation from nitrovasodilators: app rop riate choice of exogenous NO donors and aspects of p reparation and handling of aqueous NO solutions[ J ]. J Card Phar, 1991, 17 ( Supp l 3) : 25 - 33.
[ 12 ] 　SANADA M, TAGUCH IA, H IGASH I Y, et al. Forearm endothelial function and bone mineral loss in postmenopausal women [ J ].A therosclerosis, 2004, 176 (2) : 387 - 392.
[ 13 ] 　NABHAN A F . A randomized clinical trial of the effects of isosorbide mononitrate on bone formation and resorp tion in postmenopausal women: a p ilot study[ J ]. Hum Reprod, 2006, 21 ( 5 ) :
1320 - 1324.
[ 14 ] 　KIEDROWSKI L,MANEV H, COSTA E, et al. Inhibition of glutamateinduced cell death by sodium nitrop russide is not mediated by nitric oxide[ J ]. N europharm acology, 1991, 30 (6) : 1241 - 1243.
[ 15 ] 　OTSUKA E, H IRANO K,MATSUSH ITA S J, et al. Effects of nitric oxide from exogenous nitric oxide donors on osteoblastic metabolism[ J ]. Eur J Phar, 1998, 349 (2) : 345 - 350.
[ 16 ] 　GARRETT R I. Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates[N ]. WO2003105752, 2003 - 12 - 24.
[ 17 ] 　MANCIN IL,MORAD IB IDHEND IN,BECHER IN IL, et al. The Biphasic Effects of Nitric Oxide in Primary Rat Osteoblasts Are cGMP Dependent[ J ]. B ioche B iophy Res Com , 2000, 274 (2) : 477 - 481.
[ 18 ] 　H IKIJ I H, SH IN W S, O IDA S. Direct action of nitric oxide on osteoblast differentiation[ J ]. FEBS Letters, 1997, 410 ( 1 ) : 238 -242.
[ 19 ] 　AGU IRRE J, BUTTERY L,MEG O, et al. Endothelial nitric oxide synthase gene2deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in
osteoblast maturation and activity[ J ]. Am J Path, 2001, 158 ( 1) :247 - 257 .
[ 20 ] 　INOUE A, H IRUMA Y, H IROSE S. Recip rocal regulation by cyclic nucleotides of the differentiation of rat osteoblast2like cells and mineralization of nodules[ J ]. B ioc B iop Res Com , 215 (3) : 1104 -1110.
[ 21 ] 　KANAMARU Y, TAKADA T, SAURA R, et al. Effect of nitric oxide on mouse clonal ofteogenic cell,MC3T32E1, p roliferation in vitro[ J ].Kobe J M ed Sci, 2001, 47 (1) : 1 - 11.
[ 22 ] 　LAWRENCE G, RA ISA. Pathogenesis of osteoporosis: concep ts, conflicts, and p rospects[ J ]. J Clin Inv, 115 (12) : 3318 - 3325.
[ 23 ] 　WANG F S,WANG C J, YEUNGJEN. Nitric oxide donor increases osteop rotegerin p roduction and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats [ J ].
Endocrinology, 145 (5) : 2148 - 2156.
[ 24 ] 　FAN X, ROY E, ZHU L P. Nitric oxide regulates recep tor activator of nuclear factor2κ B ligand and osteop rotegerin exp ression in bone marrow stromal cells[ J ]. Endocrinology, 145 (2) : 751 - 759.
[ 25 ] 　CRYER R, BAUER D. C. Oral bisphosphonates and upper gastrointestinal tract p roblems: what is the evidence[ J ]. M ayo Clin Proc,2002, 77 (10) : 1031 - 1043
[ 26 ] 　CUMMINGS S. R, COSMAN F, JAMAL S. A. Osteoporosis. An evidencedbased guide to p revention and management [ M ].Philadelphia: American College of Physicians, 2002: 59 - 82
[ 27 ] 　CUMMINGS S R, ECKERT S, KRUEGER K A, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial [ J ]. JAMA, 1999, 281 ( 23 ) :2189 - 2197.